See All Slides - tctmd.com

Slides

Presentation CADECI 2015

NOAs for the treatment of venous thromboembolism

Presenter: Giancarlo Agnelli

February 19, 2015

Presentation

Association Between the Use of Fondaparinux vs LMWH and Clinical Outcomes in NSTEMI Patients

Presenter: Karolina Szummer

February 19, 2015

Presentation CADECI 2015

Triple Terapia Antitrombótica en Pacientes con Fibrilación Auricular y Enfermedad Coronaria: Beneficio o Amenaza ?

Presenter: Dr. J Antonio Gonz?lez-Hermosillo G

February 19, 2015

Presentation CADECI 2015

ECMO en las intervenciones de alto riesgo en las salas de intervencionismo cardiovascular

Presenter: Dr. Ren? D. G?mez

February 19, 2015

Presentation

Vorapaxar in Patients with Diabetes and Prior MI:Findings from the TRA 2ºP-TIMI 50 Trial

Presenter: M.A. Cavender

February 19, 2015

Presentation CADECI 2015

Farmacocinética de los diferentes bloqueadores de receptores de angiotensina

Presenter: Dr. Eduardo Meaney

February 19, 2015

Presentation CADECI 2015

Hibernating Myocardium

Presenter: Shahbudin H. Rahimtoola

February 19, 2015

Presentation CADECI 2015

Uso responsable de rivaroxabán en prevención secundaria tras un SICA

Presenter: Dr. Carlos Felipe Barrera-Ram?rez

February 19, 2015

Presentation CADECI 2015

Sistema de protección proximal en angioplastía carotídea_

Presenter: Juan Carlos Parodi

February 19, 2015

Presentation CADECI 2015

CASO CLINICO AORTA ABDOMINAL

Presenter: DR. ADRIAN DAVILA BORTONI

February 19, 2015

Advertisement

Slides

NOAs for the treatment of venous thromboembolism

Association Between the Use of Fondaparinux vs LMWH and Clinical Outcomes in NSTEMI Patients

Triple Terapia Antitrombótica en Pacientes con Fibrilación Auricular y Enfermedad Coronaria: Beneficio o Amenaza ?

ECMO en las intervenciones de alto riesgo en las salas de intervencionismo cardiovascular

Vorapaxar in Patients with Diabetes and Prior MI:Findings from the TRA 2ºP-TIMI 50 Trial

Farmacocinética de los diferentes bloqueadores de receptores de angiotensina

Hibernating Myocardium

Uso responsable de rivaroxabán en prevención secundaria tras un SICA

Sistema de protección proximal en angioplastía carotídea_

CASO CLINICO AORTA ABDOMINAL

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content